# Five Point Holdings, LLC: financial statements, quarterly

FPH · NYSE · CIK 1574197 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fph.md) · [Financials](/companies/fph/financials.md) · [Filings](/companies/fph/filings.md) · [Insiders](/companies/fph/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fph/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [118 d](/filings/0001574197-26-000005.md) | [9.3](/filings/0001574197-25-000059.md) | [50.8](/filings/0001574197-25-000072.md) | [16.5](/filings/0001574197-25-000084.md) | [159 d](/filings/0001574197-26-000005.md) | [12.7](/filings/0001574197-26-000020.md) | [7.0](/filings/0001574197-26-000027.md) | [13.0](/filings/0001574197-26-000035.md) | [75.4 d](/filings/0001574197-26-000005.md) | [13.0](/filings/0001574197-26-000020.md) | [13.4](/filings/0001574197-26-000027.md) | [14.1](/filings/0001574197-26-000035.md) |
| Selling, general and administrative | $m | [13.1 d](/filings/0001574197-26-000005.md) | [12.9](/filings/0001574197-25-000059.md) | [12.2](/filings/0001574197-25-000072.md) | [11.9](/filings/0001574197-25-000084.md) | [14.2 d](/filings/0001574197-26-000005.md) | [14.8](/filings/0001574197-26-000020.md) | [15.6](/filings/0001574197-26-000027.md) | [14.3](/filings/0001574197-26-000035.md) | [16.0 d](/filings/0001574197-26-000005.md) | [14.7](/filings/0001574197-26-000020.md) | [14.3](/filings/0001574197-26-000027.md) | [12.5](/filings/0001574197-26-000035.md) |
| Income tax | $m | [(4.4) d](/filings/0001574197-26-000005.md) | [1.0](/filings/0001574197-25-000059.md) | [5.9](/filings/0001574197-25-000072.md) | [1.9](/filings/0001574197-25-000084.md) | [18.8 d](/filings/0001574197-26-000005.md) | [9.5](/filings/0001574197-26-000020.md) | [1.3](/filings/0001574197-26-000027.md) | [9.2](/filings/0001574197-26-000035.md) | [8.9 d](/filings/0001574197-26-000005.md) | [(0.9)](/filings/0001574197-26-000020.md) | [6.2](/filings/0001574197-26-000027.md) | [(0.0)](/filings/0001574197-26-000035.md) |
| Net income | $m | [29.8 d](/filings/0001574197-26-000005.md) | [2.3](/filings/0001574197-25-000059.md) | [14.7](/filings/0001574197-25-000072.md) | [4.8](/filings/0001574197-25-000084.md) | [46.5 d](/filings/0001574197-26-000005.md) | [23.3](/filings/0001574197-26-000020.md) | [3.3](/filings/0001574197-26-000027.md) | [21.1](/filings/0001574197-26-000035.md) | [23.3 d](/filings/0001574197-26-000005.md) | [(2.2)](/filings/0001574197-26-000020.md) | [10.9](/filings/0001574197-26-000027.md) | [(2.6)](/filings/0001574197-26-000035.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [354](/filings/0001574197-26-000005.md) | [233](/filings/0001574197-25-000059.md) | [217](/filings/0001574197-25-000072.md) | [225](/filings/0001574197-25-000084.md) | [431](/filings/0001574197-26-000005.md) | [528](/filings/0001574197-26-000020.md) | [457](/filings/0001574197-26-000027.md) | [351](/filings/0001574197-26-000035.md) | [426](/filings/0001574197-26-000035.md) | [333](/filings/0001574197-26-000020.md) | [348](/filings/0001574197-26-000027.md) | [359](/filings/0001574197-26-000035.md) |
| Total assets | $m | [2,969](/filings/0001574197-26-000005.md) | [2,872](/filings/0001574197-24-000063.md) | [2,920](/filings/0001574197-24-000073.md) | [2,949](/filings/0001574197-24-000082.md) | [3,076](/filings/0001574197-26-000005.md) | [3,159](/filings/0001574197-25-000059.md) | [3,159](/filings/0001574197-25-000072.md) | [3,185](/filings/0001574197-25-000084.md) | [3,249](/filings/0001574197-26-000035.md) | [3,187](/filings/0001574197-26-000020.md) | [3,220](/filings/0001574197-26-000027.md) | [3,228](/filings/0001574197-26-000035.md) |
| Total liabilities | $m | [962](/filings/0001574197-25-000006.md) | [859](/filings/0001574197-24-000063.md) | [868](/filings/0001574197-24-000073.md) | [885](/filings/0001574197-24-000082.md) | [896](/filings/0001574197-26-000005.md) | [919](/filings/0001574197-25-000059.md) | [909](/filings/0001574197-25-000072.md) | [836](/filings/0001574197-25-000084.md) | [860](/filings/0001574197-26-000035.md) | [810](/filings/0001574197-26-000020.md) | [815](/filings/0001574197-26-000027.md) | [825](/filings/0001574197-26-000035.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [443](/filings/0001574197-26-000035.md) | not reported | not reported | [444](/filings/0001574197-26-000035.md) |
| Shareholders' equity | $m | [1,982](/filings/0001574197-26-000005.md) | [1,988](/filings/0001574197-25-000072.md) | [2,027](/filings/0001574197-25-000084.md) | [2,039](/filings/0001574197-25-000084.md) | [2,155](/filings/0001574197-26-000035.md) | [2,215](/filings/0001574197-26-000027.md) | [2,225](/filings/0001574197-26-000035.md) | [2,280](/filings/0001574197-26-000035.md) | [2,318](/filings/0001574197-26-000035.md) | [2,308](/filings/0001574197-26-000027.md) | [2,335](/filings/0001574197-26-000035.md) | [2,333](/filings/0001574197-26-000035.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [89.1 d](/filings/0001574197-26-000005.md) | [(26.4)](/filings/0001574197-25-000059.md) | [(23.2) d](/filings/0001574197-25-000072.md) | [(18.0) d](/filings/0001574197-25-000084.md) | [184 d](/filings/0001574197-26-000005.md) | [56.7](/filings/0001574197-26-000020.md) | [(71.6) d](/filings/0001574197-26-000027.md) | [40.4 d](/filings/0001574197-26-000035.md) | [79.7 d](/filings/0001574197-26-000005.md) | [(44.5)](/filings/0001574197-26-000020.md) | [(10.2) d](/filings/0001574197-26-000027.md) | [(18.7) d](/filings/0001574197-26-000035.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001574197-26-000005.md) | [0.1](/filings/0001574197-25-000059.md) | [0.4 d](/filings/0001574197-25-000072.md) | [0.2 d](/filings/0001574197-25-000084.md) | [0.1 d](/filings/0001574197-26-000005.md) | [0.0](/filings/0001574197-26-000020.md) | [0.1 d](/filings/0001574197-26-000027.md) | [0.0 d](/filings/0001574197-26-000035.md) | [0.1 d](/filings/0001574197-26-000005.md) | [0.0](/filings/0001574197-26-000020.md) | [0.2 d](/filings/0001574197-26-000027.md) | [0.0 d](/filings/0001574197-26-000035.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001574197-26-000035.md) | not reported | not reported | not reported | [0.0 d](/filings/0001574197-26-000035.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.